Our global presence
We supply medicines to more than 150 countries through 69 established offices in more than 50 countries and territories
Contribution to Revenue
Europe CIS
R13 622 million
(2020 (CER): R12 091 million)
2 195 Permanent employees*
Africa Middle East
R9 523 million
(2020 (CER): R8 999 million)
3 866 Permanent employees*
Australasia
R5 421 million
(2020 (CER): R5 053 million)
538 Permanent employees*
Asia
R5 194 million
(2020 (CER): R4 570 million)
1 214 Permanent employees*
Americas
R4 006 million
(2020 (CER): R3 682 million)
768 Permanent employees*
* Permanent employees excludes temporary employees (525).
Specific location details are provided www.aspenpharma.com/global-presence/
